Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia

Keyphrases

• Acute Myeloid Leukemia 100%
• Acute Myeloid Leukemia Cells 100%
• Kinase Function 100%
• PIM Kinase 100%
• Pim Kinase Inhibitor 100%
• Substrate Profiling 100%
• Kinase Substrates 100%
• Small Molecules 66%
• Ribosomal RNA Processing 66%
• Cellular Process 66%
• In Cancer 33%
• Solid Tumors 33%
• Malignant Tumor 33%
• Hematological Malignancies 33%
• Metastasis 33%
• Tumor Growth 33%
• Provirus 33%
• Cell Survival 33%
• Durable Response 33%
• Patients with Cancer 33%
• Path Analysis 33%
• Armamentarium 33%
• Malignant Disease 33%
• Leukemia Cell Lines 33%
• Inflammation Cells 33%
• Tumor Metabolism 33%
• Pro-tumorigenic 33%
• Moloney murine Leukemia Virus 33%
• RNA Splicing 33%
• Integration Site 33%
• SF3B1 33%
• PIM-1 33%
• In-gel Kinase Assay 33%
• Serine-arginine Protein Kinase 1 (SRPK1) 33%
• RNA Polymerase I Inhibitor 33%
• Targetable 33%
• Serine/threonine Kinase 33%
• Immune Cell Invasion 33%
• Splicing Modulators 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Myeloid Leukemia 100%
• Phosphotransferase 100%
• Malignant Neoplasm 28%
• Cellular Processes 28%
• Ribosome RNA 28%
• Diseases 28%
• Neoplasm 14%
• Inflammation 14%
• Solid Malignant Neoplasm 14%
• Phosphotransferase Inhibitor 14%
• Protein Kinases 14%
• Tumor Growth 14%
• Hematologic Malignancy 14%
• DNA Directed RNA Polymerase 14%
• Moloney Murine Leukemia Virus 14%
• Protein Serine Threonine Kinase 14%
• Serine Arginine Rich Protein 14%